索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]杨铠瑞,孙煌,柴圣杰,等.二尖瓣反流诊断策略及手术治疗进展[J].国际心血管病杂志,2023,01:13-16.
点击复制

二尖瓣反流诊断策略及手术治疗进展(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2023年01期
页码:
13-16
栏目:
综述
出版日期:
2023-01-20

文章信息/Info

Title:
-
作者:
杨铠瑞; 孙煌; 柴圣杰; 赵双凤; 彭云珠
650032 昆明医科大学第一附属医院心血管内科
Author(s):
-
关键词:
二尖瓣反流; 二尖瓣修复; 二尖瓣置换; 二尖瓣脱垂
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2023.01.004
文献标识码:
-
摘要:
二尖瓣反流是成人心脏瓣膜病最常见的类型，发病率和死亡率较高。目前二 尖瓣反流诊断技术不断提高，通过超声心动图、心脏磁共振及心脏计算机断层扫描技术，人 们对二尖瓣结构的认识更加深入。在药物治疗的基础上，外科及介入手术治疗推陈出新，以 MitralClip 缘对缘修复术为代表的介入治疗技术的发展，提升了疗效及安全性，使更多患者 获益。
Abstract:
-

参考文献/References

[1] Hu P, Liu XB, Liang J, et al. A hospital-based survey of patients with severe valvular heart disease in China[J]. Int J Cardiol, 2017, 231:244-247.
[2] Marciniak A, Glover K, Sharma R. Cohort profile: prevalence of valvular heart disease in community patients with suspected heart failure in UK[J]. BMJ Open, 2017, 7(1):e012240.
[3] Goel SS, Bajaj N, Aggarwal B, et al. Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need[J]. J Am Coll Cardiol, 2014, 63(2):185-186.
[4] Dziadzko V, Clavel MA, Dziadzko M, et al. Outcome and undertreatment of mitral regurgitation: a community cohort study[J]. Lancet, 2018, 391(10124):960-969.
[5] Miller MA, Dukkipati SR, Turagam M, et al. Arrhythmic mitral valve prolapse: JACC review topic of the week[J]. J Am Coll Cardiol, 2018, 72(23 Pt A):2904-2914.
[6] Lee APW, Jin CN, Fan YT, et al. Functional implication of mitral annular disjunction in mitral valve prolapse: a quantitative dynamic 3D echocardiographic study[J]. JACC Cardiovasc Imaging, 2017, 10(12):1424-1433.
[7] Perazzolo Marra M, Basso C, De Lazzari M, et al. Morphofunctional abnormalities of mitral annulus and arrhythmic mitral valve prolapse[J]. Circ Cardiovasc Imaging, 2016, 9(8):e005030.
[8] Aman E, Smith TW. Echocardiographic guidance for transcatheter mitral valve repair using edge-to-edge clip[J]. J Echocardiogr, 2019, 17(2):53-63.
[9] Namazi F, van der Bijl P, Hirasawa K, et al. Prognostic value of left ventricular global longitudinal strain in patients with secondary mitral regurgitation[J]. J Am Coll Cardiol, 2020, 75(7):750-758.
[10] Garg P, Swift AJ, Zhong L, et al. Assessment of mitral valve regurgitation by cardiovascular magnetic resonance imaging[J]. Nat Rev Cardiol, 2020, 17(5):298-312.
[11] Bui AH, Roujol S, Foppa M, et al. Diffuse myocardial fibrosis in patients with mitral valve prolapse and ventricular arrhythmia[J]. Heart, 2017, 103(3):204-209.
[12] Dejgaard LA, Skj?lsvik ET, Lie ?H, et al. The mitral annulus disjunction arrhythmic syndrome[J]. J Am Coll Cardiol, 2018, 72(14):1600-1609.
[13] Weir-McCall JR, Blanke P, Naoum C, et al. Mitral valve imaging with CT: relationship with transcatheter mitral valve interventions[J]. Radiology, 2018, 288(3):638-655.
[14] Stone GW, Weissman NJ, Mack MJ, et al. Transcatheter mitral-valve repair in patients with heart failure[J]. N Engl J Med, 2019, 380(20):1980-1981.
[15] Detaint D, Sundt TM, Nkomo VT, et al. Surgical correction of mitral regurgitation in the elderly: outcomes and recent improvements[J]. Circulation, 2006, 114(4):265-272.
[16] Ruiz CE, Hahn RT, Berrebi A, et al. Clinical trial principles and endpoint definitions for paravalvular leaks in surgical prosthesis: an expert statement[J]. J Am Coll Cardiol, 2017, 69(16):2067-2087.
[17] Goldstone AB, Chiu P, Baiocchi M, et al. Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement[J]. N Engl J Med, 2017, 377(19):1847-1857.
[18] Mehaffey HJ, Hawkins RB, Schubert S, et al. Contemporary outcomes in reoperative mitral valve surgery[J]. Heart, 2018, 104(8):652-656.
[19] Chikwe J, Chiang YP, Egorova NN, et al. Survival and outcomes following bioprosthetic vs mechanical mitral valve replacement in patients aged 50 to 69 years[J]. JAMA, 2015, 313(14):1435-1442.
[20] Obadia JF, Messika-Zeitoun D, Leurent G, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation[J]. N Engl J Med, 2018, 379(24):2297-2306.
[21] Fishbein GA, Fishbein MC. Mitral valve pathology[J]. Curr Cardiol Rep, 2019, 21(7): 61.
[22] Kuwata S, Taramasso M, Guidotti A, et al. Ongoing and future directions in percutaneous treatment of mitral regurgitation[J]. Expert Rev Cardiovasc Ther, 2017, 15(6):441-446.
[23] Walther C, Fichtlscherer S, Holubec T, et al. New developments in transcatheter therapy of mitral valve disease[J]. J Thorac Dis, 2020, 12(4):1728-1739.
[24] Mauri V, Besler C, Riebisch M, et al. German multicenter experience with a new leaflet-based transcatheter mitral valve repair system for mitral regurgitation[J]. JACC Cardiovasc Interv, 2020, 13(23):2769-2778.
[25] Geis NA, Schlegel P, Heckmann MB, et al. One-year results following PASCAL-based or MitraClip-based mitral valve transcatheter edge-to-edge repair[J]. ESC Heart Fail, 2022, 9(2):853-865.
[26] Ger?ek M, Roder F, Rudolph TK, et al. PASCAL mitral valve repair system versus MitraClip: comparison of transcatheter edge-to-edge strategies in complex primary mitral regurgitation[J]. Clin Res Cardiol, 2021, 110(12):1890-1899.
[27] Webb JG, Hensey M, Szerlip M, et al. 1-year outcomes for transcatheter repair in patients with mitral regurgitation from the CLASP study[J]. JACC Cardiovasc Interv, 2020, 13(20):2344-2357.
[28] Nickenig G, Schueler R, Dager A, et al. Treatment of chronic functional mitral valve regurgitation with a percutaneous annuloplasty system[J]. J Am Coll Cardiol, 2016, 67(25):2927- 2936.
[29] Weber M, ?ztürk C, Taramasso M, et al. Leaflet edge-to-edge treatment versus direct annuloplasty in patients with functional mitral regurgitation[J]. EuroIntervention, 2019, 15(10):912- 918.
[30] Colli A, Manzan E, Aidietis A, et al. An early European experience with transapical off-pump mitral valve repair with NeoChord implantation[J]. Eur J Cardiothorac Surg, 2018, 54(3):460-466.
[31] Yoon SH, Whisenant BK, Bleiziffer S, et al. Transcatheter mitral valve replacement for degenerated bioprosthetic valves and failed annuloplasty rings[J]. J Am Coll Cardiol, 2017, 70(9):1121-1131.
[32] Sorajja P, Moat N, Badhwar V, et al. Initial feasibility study of a new transcatheter mitral prosthesis: the first 100 patients[J]. J Am Coll Cardiol, 2019, 73(11):1250-1260.
[33] Zahr F, Song HK, Chadderdon SM, et al. 30-day outcomes following transfemoral transseptal transcatheter mitral valve replacement: intrepid TMVR early feasibility study results[J]. JACC Cardiovasc Interv, 2022, 15(1):80-89.
[34] Hendrickson MJ, Bhyan P, Arora S, et al. Trends in inpatient complications and readmissions after transcatheter or surgical mitral valve repair from 2012 to 2016[J]. JACC Cardiovasc Interv, 2020, 13(2):272-274.

备注/Memo

备注/Memo:
基金项目：云南省卫生科技计划项目（2018NS0098）；云南省科技 计划项目（2018BA064）；昆明医科大学研究生创新基金（2020S142）
通信作者：彭云珠， E-mail：pengyunzhu0308@163.com
更新日期/Last Update: 2023-01-20